Eppendorf Licenses Technology for Thermal Cyclers to Roche

HAMBURG, Germany, April 4, 2011 /PRNewswire/ -- Eppendorf AG has licensed patents covering gradient technology for thermal cyclers to F. Hoffmann-La Roche Ltd for use e.g. in their real-time Thermal Cyclers, including US patent Nos. 6,767,512 and 7,074,367. Eppendorf utilizes the technology in its Eppendorf Mastercycler(R) pro gradient, Mastercycler gradient and Mastercycler ep realplex models.

Eppendorf AG, based in Hamburg, Germany, develops, produces and distributes instruments and consumables for the Life Science research industry. Additional information is available at: http://www.eppendorf.com

About Roche

Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world's largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. Roche's personalised healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients. In 2010, Roche had over 80'000 employees worldwide and invested over 9 billion Swiss francs in R&D. The Group posted sales of 47.5 billion Swiss francs. Genentech, United States, is a wholly owned member of the Roche Group. Roche has a majority stake in Chugai Pharmaceutical, Japan. For more information: http://www.roche.com

    Contact:

    Sven Buelow, Ph.D.
    Executive Vice President
    Corporate Development
    Eppendorf AG
    Barkhausenweg 1
    22339 Hamburg
    Germany
    Phone: +49-40-53801-500
    Fax: +49-40-53801-757
    e-mail: [email protected]

SOURCE Eppendorf AG